Toll-like receptor (TLR) 2 and TLR4 deficiencies exert differential in vivo effects against Schistosoma japonicum

Parasite Immunology

Volumn 33, Issue 4, 2011, Pages 199-209

  Zhang, M ^a,b   Gao, Y ^a   Du, X ^a   Zhang, D ^a,c   Ji, M ^a,c   Wu, G ^a,c  

^a NANJING MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c Jiangsu Province Key Laboratory of Modern Pathogen Biology   (China)

Author keywords

Cytotoxicity related genes; Schistosoma japonicum; Th response; Toll like receptors 2; Toll like receptors 4

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 4; MESSENGER RNA; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GENE EXPRESSION; IMMUNE RESPONSE; IN VIVO STUDY; INNATE IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS JAPONICA; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL;

ANIMALS; GENE EXPRESSION PROFILING; INTERFERON-GAMMA; INTERLEUKIN-12; INTERLEUKIN-4; LYMPH NODES; MICE; MICE, KNOCKOUT; MICROARRAY ANALYSIS; RNA, MESSENGER; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS JAPONICA; SKIN; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

MUS; SCHISTOSOMA JAPONICUM;

EID: 79952602211     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/j.1365-3024.2010.01265.x     Document Type: Article

References (34)

1. Janeway CA Jr. Approaching the asymptote? Evolution and revolution in immunology Cold Spring Harb Symp Quant Biol 1989; 54(Pt 1): 1-13.
2. Iwasaki A & Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol 2004; 5: 987-995.
3. Beutler B. Inferences, questions and possibilities in Toll-like receptor signalling. Nature 2004; 430: 257-263.
4. Gazzinelli RT & Denkers EY. Protozoan encounters with Toll-like receptor signalling pathways: implications for host parasitism. Nat Rev Immunol 2006; 6: 895-906.
5. Janeway CA Jr & Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002; 20: 197-216.
6. Harnett W & Harnett MM. Molecular basis of worm-induced immunomodulation. Parasite Immunol 2006; 28: 535-543.
7. Perrigoue JG, Marshall FA & Artis D. On the hunt for helminths: innate immune cells in the recognition and response to helminth parasites. Cell Microbiol 2008; 10: 1757-1764.
8. McManus DP & Loukas A. Current status of vaccines for schistosomiasis. Clin Microbiol Rev 2008; 21: 225-242.
9. Thomas PG, Carter MR, Atochina O, et al. Maturation of dendritic cell 2 phenotype by a helminth glycan uses a Toll-like receptor 4-dependent mechanism. J Immunol 2003; 171: 5837-5841.
10. van der Kleij D, Latz E, Brouwers JF, et al. A novel host-parasite lipid cross-talk. Schistosomal lyso-phosphatidylserine activates toll-like receptor 2 and affects immune polarization. J Biol Chem 2002; 277: 48122-48129.
11. Jenkins SJ, Hewitson JP, Ferret-Bernard S & Mountford AP. Schistosome larvae stimulate macrophage cytokine production through TLR4-dependent and independent pathways. Int Immunol 2005; 17: 1409-1418.
12. + cells is a major feature of the innate immune response in mice that develop Th1-mediated protective immunity to Schistosoma mansoni. Infect Immun 2003; 71: 3563-3571.
13. Guo CJ, Pan Q, Li DG, Sun H & Liu BW. A miR-15b and miR-16 are implicated in activation of the rat hepatic stellate cell: an essential role for apoptosis. J Hepatol 2009; 50: 766-778.
14. Murawski MR, Bowen GN & Cerny AM. Respiratory syncytial virus activates innate immunity through toll-like receptor 2. J Virol 2009; 83: 1492-1500.
15. Tjarnlund A, Guirado E, Julian E, Cardona PJ & Fernandez C. Determinant role for Toll-like receptor signalling in acute mycobacterial infection in the respiratory tract. Microbes Infect 2006; 8: 1790-1800.
16. Fuse ET, Tateda K, Kikuchi Y, et al. Role of Toll-like receptor 2 in recognition of Legionella pneumophila in a murine pneumonia model. J Med Microbiol 2007; 56: 305-312.
17. Blasi E, Mucci A, Neglia R, et al. Biological importance of the two Toll-like receptors, TLR2 and TLR4, in macrophage response to infection with Candida albicans. FEMS Immunol Med Microbiol 2005; 44: 69-79.
18. Gil ML & Gozalbo D. TLR2, but not TLR4, triggers cytokine production by murine cells in response to Candida albicans yeasts and hyphae. Microbes Infect 2006; 8: 2299-2304.
19. van der Graaf CA, Netea MG, Verschueren I, van der Meer JW & Kullberg BJ. Differential cytokine production and Toll-like receptor signaling pathways by Candida albicans blastoconidia and hyphae. Infect Immun 2005; 73: 7458-7464.
20. Debierre-Grockiego F, Campos MA, Azzouz N, et al. Activation of TLR2 and TLR4 by glycosylphosphatidylinositols derived from Toxoplasma gondii. J Immunol 2007; 179: 1129-1137.
21. Mun HS, Aosai F, Norose K, et al. TLR2 as an essential molecule for protective immunity against Toxoplasma gondii infection. Int Immunol 2003; 15: 1081-1087.
22. Kropf P, Freudenberg MA, Modolell M, et al. Toll-like receptor 4 contributes to efficient control of infection with the protozoan parasite Leishmania major. Infect Immun 2004; 72: 1920-1928.
23. Kurt-Jones EA, Chan M, Zhou S, et al. Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc Natl Acad Sci USA 2004; 101: 1315-1320.
24. Medzhitov R & Janeway CA Jr. Innate immunity: impact on the adaptive immune response. Curr Opin Immunol 1997; 9: 4-9.
25. Layland LE, Rad R & Wagner H. Immunopathology in schistosomiasis is controlled by antigen-specific regulatory T cells primed in the presence of TLR2. Eur J Immunol 2007; 37: 2174-2184.
26. Nocentini G & Riccardi C. GITR: a modulator of immune response and inflammation. Adv Exp Med Biol 2009; 647: 156-173.
27. Chavez-Galan L, Arenas-Del Angel MC, Zenteno E, Chavez R & Lascurain R. Cell death mechanisms induced by cytotoxic lymphocytes. Cell Mol Immunol 2009; 6: 15-25.
28. Asseman C, Pancre V, Quatennens B & Auriault C. Schistosoma mansoni-infected mice show augmented hepatic fibrosis and selective inhibition of liver cytokine production after treatment with anti-NK1.1 antibodies. Immunol Lett 1996; 54: 11-20.
29. Mountford AP, Anderson S & Wilson RA. Induction of Th1 cell-mediated protective immunity to Schistosoma mansoni by co-administration of larval antigens and IL-12 as an adjuvant. J Immunol 1996; 156: 4739-4745.
30. Speziali E, Bethony J, Martins-Filho O, et al. Production of interferon-gamma by natural killer cells and aging in chronic human schistosomiasis. Mediators Inflamm 2004; 13: 327-333.
31. Cascalho M & Platt JL. Novel functions of B cells. Crit Rev Immunol 2007; 27: 141-151.
32. Lundy SK, Lerman SP & Boros DL. Soluble egg antigen-stimulated T helper lymphocyte apoptosis and evidence for cell death mediated by FasL(+) T and B cells during murine Schistosoma mansoni infection. Infect Immun 2001; 69: 271-280.
33. Layland LE, Mages J, Loddenkemper C, et al. Pronounced phenotype in activated regulatory T cells during a chronic helminth infection. J Immunol 2010; 184: 713-724.
34. Shevach EM, DiPaolo RA, Andersson J, Zhao DM, Stephens GL & Thornton AM. The lifestyle of naturally occurring CD4+ CD25+ Foxp3+ regulatory T cells. Immunol Rev 2006; 212: 60-73.